Carolyn Cross

Chairman and CEO, Ondine Biomedical Inc.

With a background in finance and institutional investing, Carolyn Cross has over 30 years’ experience with public market securities and working with early stage companies. Earlier in her career, Ms. Cross was a portfolio manager and Vice President for Royal Bank Investment Management Inc. Ms. Cross currently sits on the boards and audit committees of Greystone Capital Management Inc., Sinuwave Technologies Corporation and Cayoose Creek Development Ltd., a First Nations project management services company based in BC.  She is a Board Member and Treasurer of the International Photodynamic Association (IPA) and currently sits on The National Research Council (NRC)—the  Government of Canada's premier organization for research and development. Ms. Cross is a past Director of the Board of the Canada Foundation of Innovation and past member of its Audit and Finance Committee.  She is a Member of the World Innovation Health Network (WIN) Advisory Council, The Odette School of Business, University of Windsor, a Founding Member of the Ernst & Young Global Women in Business Advisory Council, and a member of the Advisory Council of GroYourBiz, a national organization assisting Canadian Women Entrepreneurs. She has been the recipient of several awards including the  Meritorious Service Cross by the Governor General of Canada and the Queen Elizabeth II Diamond Jubilee Award from the Government of Canada. Ms. Cross holds a CFA designation, an MBA from York University and an Honours in Business Administration (HBA) from the University of Western Ontario. 

 

WIN’s Advisory Council acts as a visible body of leadership, influence and support for the ground-breaking work that WIN executes. These Canadian and international advisors, ambassadors and connectors further WIN’s goals while contributing business and health system expertise to scale innovation and drive impactful change in healthcare.